SUMMARY Vasodilatory responses of segments of large epicardial left coronary artery (CA), small intramyocardial CAs (0.3-1.0 mm), coronary stenoses and CAs filled by collaterals were determined in 34 patients. Measurements were made before and after nitroglycerin (0.4 mg, sublingual) by means of quantitative magnification coronary angiography using photospot film and a calibrated 6-power viewing device. The left main CA, proximal, middle and distal anterior descending and circumflex segments, and small CAs showed dilatation that varied in magnitude. When magnitude of dilatation was compared with control diameter of the vessel and its location, control diameter proved to be the significant independent variable. CAs with the smallest control diameter showed the greatest magnitude of vasodilatation. CA branches filled by collaterals had vasodilatation similar in magnitude to that of CAs of comparable control diameter. Although coronary stenoses dilated, the magnitude of dilatation was less than that observed in nonstenosed arterial segments of similar control diameter. When areas of stenosis were excluded, however, results were similar regardless of whether the patient had CA disease. These data indicate that a principal determinant of the CA vasodilatory response to nitroglycerin is the size of the artery before nitroglycerin.
The purpose of this study was to quantify left CA dilatation responses to nitroglycerin in patients with and without CA disease (CAD). Special attention was given to the control diameter and location of the CA segment relative to the left coronary ostium. We arbitrarily divided the left CA system into eight large (diameter > 1.0 mm) epicardial CA segments and small (diameter < 1.0 mm) intramural CAs. Vasodilatation responses of these CA segments to nitroglycerin was measured by quantitative angiography.
Propranolol treatment was not interrupted, but nitrates were withheld for at least 6 hours before catheterization. The patients were in a postabsorptive state without premedication when catheterized. A #8F Sones catheter was advanced from the right brachial artery to the left ventricle. Pressures were measured and the catheter was withdrawn to the aortic root. Mean aortic pressure was obtained by electronic filtration.
Coronary Angiographic Technique
Multiple views of the left CA were obtained using conventional 35-mm cine technique. Fluoroscopic images were simultaneously recorded on a video disk recorder (Videomatic disk recorder, General Electric, OM C7560B). These recordings were reviewed and a right anterior oblique projection was chosen to minimize overlapping of proximal left CA branches and maximize visualization of any proximal coronary stenosis. Projections ranged from 1040% rotation with various degrees of sagittal plane angulation. After ECG and pressure changes related to selective injection of coronary contrast material had reverted (-5 minutes), a control 105-mm photospot selective coronary angiogram was filmed using 6 ml of Renografin 76. The filming rate was 4-6 frames/sec, with CA segments of interest positioned in the central portion of the image field. A photospot camera (General Electric), Kodak 2541 film, 11.5-cm or 15-
cm image magnification (General Electric Flurocon) and a 3-mm focal spot were used with this technique.
After the control angiogram was filmed, the patient was rotated to the horizontal position. When heart rate and aortic pressure were constant (± 5%), they were recorded and the Sones catheter was advanced to the left ventricle to record pressure at low and high gain. A 0.4-mg freshly crushed nitroglycerin tablet (Lilly) was given sublingually. Pressure and ECG were monitored for 5 minutes after the tablet dissolved. Left ventricular pressure recordings were made, and the catheter was withdrawn to the aortic root. An angiogram was filmed after nitroglycerin with the same technique and projection used for the control angiogram.
In three additional patients nitroglycerin was omitted, and 5 minutes after the first control angiogram, a second control angiogram was filmed with the same technique.
Measurements of Coronary Artery Diameter
Our quantitative coronary angiographic technique has been described in detail.'2 Briefly, photospot angiogram frames were viewed on a standard x-ray view box. Frames filmed in end-diastole from both control and nitroglycerin angiograms were selected. A hand-held magnifying comparator (Finescale), fitted with a reticle containing 0.1-mm divisions (No. 122 Finescale), was placed over the opacified artery. Viewed through the eyepiece, the scale and underlying CA segments or catheter were both magnified 6 times. Measurements were made to the nearest 0.1 mm at branch points. All measurements were made near the center of the photographic field, which makes additional correction for pincushion distortion unnecessary.
The Sones catheter was measured at its tip, which was positioned within the left main CA ostium. The epicardial left CA was divided in a manner similar to that proposed by the American Heart Association (fig. l).13 The left main CA was measured just before its bifurcation. The anterior descending (AD) CA was measured proximal to the first septal perforating branch (proximal AD), just distal to the second septal perforating branch (middle AD) and at a branch point near the apex (distal AD). The circumflex (Cx) CA was measured proximal to the origin of the obtuse marginal branch (proximal Cx), at the obtuse marginal branch at its origin ( Twenty-seven CA segments from the left main CA through small CAs (range of initial CA diameters 4.2-0.6 mm) were measured' from the three sets of paired angiograms done 5 minutes apart without intervention. The diameters were similar (0 ± 2%, p -NS, range -5% to 5%) because only six of the 27 CA segments appeared to change their initial diameter (three increased and three decreased 0.1 mm).
Hemodynamic and Angiographic Responses to Nitroglycerin
When patients with and without CAD were compared, hemodynamic and angiographic (excluding coronary stenoses) responses were similar (p 2 0.28). Thus, hemodynamico and angiographic values of patients with and without CAD 'were combined in subsequent analysis of results.
Effect of Nitroglycerin on Heart Rate and Aortic and Left Ventricular Pressures
Compared with values obtained after the control angiogram, heart rate increased 5 6 beats/min, mean aortic pressure decreased 10 diameters observed before nitroglycerin by the equation in table 1.
Effect of Nitroglycerin on Diameter of Proximal Anterior Descending and Circumflex Arteries
The proximal AD segment measured 2.83 ± 0.68 mm before and 3.28 ± 0.66 mm after nitroglycerin (p < 0.01). The proximal Cx segment measured 2.72 ± 0.77 mm before and 3.10 ± 0.72 mm after nitro- 
Effect of Nitroglycerin on Diameter of Distal Anterior Descending and Circumflex Arteries
The distal AD segment measured 1.51 ± 0.34 mm before and 1.90 ± 0.37 mm after nitroglycerin (p < 0.01). The distal Cx segment measured 1.34 ± 0.31 mm before and 1.67 ± 0.36 mm after nitroglycerin (p < 0.01). The diameters of the distal AD and Cx were similar (p = NS) before and after nitroglycerin. Percentages of dilatation of distal AD (26%) and Cs (25%) were similar (p = NS). Responses for distal AD and Cx are shown in figure 2D . Diameters of distal AD and Cx after nitroglycerin were related to diameters before nitroglycerin by the equations in table 1.
Effect of Nitroglycerin on Diameter of Small Coronary Arteries
The diameter of small intramyocardial CAs measured 0.64 ± 0.19 mm before and 0.79 ± 0.22 mm after nitroglycerin (p < 0.01) (fig. 2E ). The average percentage of dilatation was 23%. Diameters of small CAs after nitroglycerin were related to diameters before nitroglycerin by the equation in table 1.
Effect of Nitroglycerin on Arteries Filled by Collaterals
The diameter of CAs filled by collaterals was 0.99 i 0.52 mm before and 1.27 ± 0.60 mm after nitroglycerin ( fig. 2F) The percentage of dilatation of the left main CA was less than that of proximal, middle, and distal AD and Cx CAs, small CAs and CAs filled by collaterals (p < 0.05). The percentage of dilatation of proximal CAs was less than that of middle and distal AD and Cx CAs, small CAs and CAs filled by collaterals (p < 0.05). The percentage of dilatation of middle and distal AD and Cx CAs, small CAs and CAs filled by collaterals was similar (p = NS).
These percentages of dilatation were related to control CA diameter (p < 0.01) but not to location (left main, proximal, middle and distal CAs, small CAs, and CAs filled by collaterals) (p = NS) ( fig. 3) . For example, the percentage of dilatation of a 2-mm CA was usually greater than dilatation observed in a 3-mm CA, regardless of location.
Effect of Nitroglycerin on Coronary Stenoses
The minimal diameter of each of 41 coronary stenoses ranged from 0.5-2. 2G). Dilatation averaged 6%, but varied; 18 of 41 dilated at least 0.1 mm. The diameter of a stenosed CA before nitroglycerin had a bearing on whether or not it dilated. Only two of 14 narrowed segments with a diameter < 1.2 mm dilated at least 0.1 mm (average 2%, p = NS), whereas 16 of 27 narrowed segments . 1.3 mm in diameter dilated at least 0.1 mm (average 1 1%, p < 0.01).
The average percentage of coronary diameter reduction was 46 ± 15% before nitroglycerin and 50 + 14% after nitroglycerin (p < 0.01). The range of change was -9% to 18%. Of the 41 narrowed segments the percentage of narrowing increased in 29, decreased in seven and was unchanged in five ( fig. 4) . This tendency to an increase in percentage of narrowing after nitroglycerin was usually the result of greater dilatation in the prestenotic segment (0.38 ± 0.23 mm) than in the narrowed segment (0.10 + 0.13 mm, p < 0.01). In patients with CAD, the changes in proximal and middle AD and Cx segments immediately proximal to a narrowing (16 ± 11%) were not significantly different (p = NS) from changes in CA segments of similar location (22 ± 14%) that were not adjacent to a narrowing. Additionally, these changes were similar (p = NS) to changes in CA segments of similar location (21 + 15%) from patients with normal angiograms.
Discussion
The purpose of this study was to quantify the dilatative effects of nitroglycerin on the left CA. Dilatation '7 did not specify where measurements were made. In both studies, nitrates may sometimes have been administered before angiography, and some patients were probably receiving propranolol, whereas others were not. All of our patients were receiving propranolol, which may have affected our results. Beta blockade could cause a decrease in CA diameter and alter the dilatation response to nitroglycerin. Because CAs taper as the distance from the ostium increases and the percentage of dilatation depends on CA size, it was also important to define the exact site measured.
Before nitroglycerin the diameter of all left CA segments and the percentage of dilatation were similar in patients with and without CAD. In contrast, Vieweg et al. '8 reported that the CA lumen was slightly smaller in patients with CAD than in those with normal angiograms. Gensini those with normal CAs when obviously narrowed segments were excluded. A trend that was not significant suggested that certain CA segments immediately adjacent to a stenosis dilated less than others farther from stenoses. It was possible that these CA segments were less affected by the atherosclerotic process, e.g., less than stenoses but more than CA segments farther from stenoses. This lack of difference compared with findings of Gensini et al.8 could relate to the dose of nitroglycerin used by us or to different techniques. Perhaps measurements made at obviously diseased locations will show a decreased responsiveness, whereas more dilatation will occur in other CA segments from patients with CAD. Similar hemodynamic effects of nitroglycerin occurred in patients with and without CAD in this study and in our previous reports." 2 Small AD and Cx intramyocardial CA branches (0.3-1.0 mm) dilated after nitroglycerin. Winbury and co-workers" 6 found that nitroglycerin decreased pressure gradients across epicardial CAs for long periods of time, although total resistance transiently decreased and then increased. From these observations, they postulated that nitroglycerin preferentially dilated large CAs compared with small resistance vessels. In experiments using animal models with a ligated CA, nitroglycerin usually improved perfusion and function of regions supplied by the ligated CA. '9-24 To explain the potential for improved perfusion of the ischemic region after nitroglycerin, Winbury et al. 6 proposed that intramyocardial tributary CAs connecting epicardium with endocardium dilate after nitroglycerin; therefore, flow to collaterally perfused vessels increases. These tributary CAs were thought to respond to nitroglycerin in a manner similar to that of large epicardial CAs, but no direct measurements within intramyocardial CAs were made. Dilatation of small intramyocardial CAs observed in this study support the theory of Winbury and colleagues that nitroglycerin can dilate some intramyocardial CAs. This effect would potentially increase flow to regions dependent on collateral flow. In addition to dilatation of tributary arteries, the physiologic effect of nitroglycerin will depend on nitroglycerin-induced changes in heart rate, coronary perfusion pressure and left ventricular filling pressure. Recent animal experiments by several groups also show that vasoactive drugs may change distal coronary pressure and alter coronary hemodynamics separate from changes in aortic pressure.25-80 It is not known whether these changes occur in patients with coronary stenoses, but that possibility should be considered when speculating on the action of nitroglycerin in patients with CAD. Additionally, although hemodynamic and angiographic values for patients with and without CAD were combined in the analysis, reduced perfusion pressure may have different effects in patients with and in those without CAD with respect to the diameter of coronary vessels distal to a stenosis.
In contrast to the supportive observations of Winbury and co-workers," findings of in vitro studies by other investigators differed from ours in that large and small CAs responsed differently to nitroglycerin. Schnaar and Sparks" compared the effects of nitroglycerin on isolated large (diameter -2.0 mm) and small (diameter -0.5 mm) CAs in dogs and found quantitatively different degrees of relaxation. Harder et al.,81 using a similar preparation, observed quantitatively different effects of nitroglycerin on the action potential of large (diameter > 1.0 mm) and small (diameter < 0.5 mm) CAs. Both groups reported that nitroglycerin had a greater effect on large CAs. In both studies, adenosine, believed to predominantly affect resistance vessels, had an action opposite to that of nitroglycerin on these responses. These findings suggested that CAs 0.3-0.5 mm in diameter have a major effect on coronary resistance.
Observations 
